Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belotero Intense vs Belotero Intense Lidocaine for facial volume enhancement
DRKS00031800Phase 4Completed
- Sponsor
- Merz
- Start
- May 2023
- Modality
- Recombinant Proteins and Enzymes, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of belotero and hyaluronic acid + lidocaine in None and marionette lines (2 arms), sponsored by Merz. Started May 2023; status: completed.
02
Drugs
beloterohyaluronic acid + lidocaine
03
Conditions
marionette lines
Beyond the preview
Go deeper on DRKS00031800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00031800.